115 related articles for article (PubMed ID: 22840921)
1. Treatment for patients with catecholaminergic polymorphic ventricular tachycardia: are we in need of randomized trials?
Wilde AA; van der Werf C
J Electrocardiol; 2012; 45(6):739-40. PubMed ID: 22840921
[No Abstract] [Full Text] [Related]
2. Effects of flecainide therapy on inappropriate shocks and arrhythmias in catecholaminergic polymorphic ventricular tachycardia.
Jacquemart C; Ould Abderrahmane F; Massin MM
J Electrocardiol; 2012; 45(6):736-8. PubMed ID: 22672791
[TBL] [Abstract][Full Text] [Related]
3. Flecainide suppresses defibrillator-induced storming in catecholaminergic polymorphic ventricular tachycardia.
Hong RA; Rivera KK; Jittirat A; Choi JJ
Pacing Clin Electrophysiol; 2012 Jul; 35(7):794-7. PubMed ID: 22553997
[TBL] [Abstract][Full Text] [Related]
4. Ventricular oversensing after replacement of an implantable cardioverter-defibrillator.
Arias MA; Puchol A; Castellanos E; Pachón M; Rodríguez-Padial L
Pacing Clin Electrophysiol; 2009 Jul; 32(7):925-7. PubMed ID: 19572871
[No Abstract] [Full Text] [Related]
5. Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia.
Khoury A; Marai I; Suleiman M; Blich M; Lorber A; Gepstein L; Boulos M
Heart Rhythm; 2013 Nov; 10(11):1671-5. PubMed ID: 23954267
[TBL] [Abstract][Full Text] [Related]
6. Induction of ventricular tachycardia by alternate current due to an insufficiently grounded electrical system.
Lappegård KT
Pacing Clin Electrophysiol; 2012 Jun; 35(6):e170-2. PubMed ID: 21091734
[TBL] [Abstract][Full Text] [Related]
7. Catecholaminergic polymorphic ventricular tachycardia: important messages from case reports.
van der Werf C; Wilde AA
Europace; 2011 Jan; 13(1):11-3. PubMed ID: 20851823
[No Abstract] [Full Text] [Related]
8. Failure of an ICD to Deliver Antitachycardia Therapy against Recurrent, Sustained Ventricular Tachycardia: What's the Mechanism?
Willoughby MC; Diamantakos E; Dorman AK; Pires LA
Pacing Clin Electrophysiol; 2016 Jan; 39(1):95-8. PubMed ID: 26310862
[No Abstract] [Full Text] [Related]
9. Averaging detection algorithm of ICDs: not so shocking after all!
Barold SS; Herweg B
Pacing Clin Electrophysiol; 2008 Jan; 31(1):17-9. PubMed ID: 18181905
[No Abstract] [Full Text] [Related]
10. Initiation of ventricular tachycardia by interruption of pacemaker-mediated tachycardia in a patient with a dual-chamber implantable cardioverter defibrillator.
Van Gelder BM; Meijer A; Dekker LR; Bracke FA
Pacing Clin Electrophysiol; 2009 Sep; 32(9):1227-30. PubMed ID: 19719503
[TBL] [Abstract][Full Text] [Related]
11. ICD proarrhythmia as a consequence of an interaction with an algorithm to prevent atrial arrhythmias.
Martínez-Sánchez J; García-Alberola A; Sánchez-Muñoz JJ; Peñafiel-Verdú P; Giner-Caro JA; Valdés-Chávarri M
Pacing Clin Electrophysiol; 2009 Aug; 32(8):1096-8. PubMed ID: 19659632
[TBL] [Abstract][Full Text] [Related]
12. Inappropriate Shocks in a Patient with Subcutaneous ICD and Transvenous Pacemaker: Is it as it Seems?
Santucci LM; Saputo FA; Verticelli L; Tamburri I; Placidi S; Silvetti MS; Drago F
Pacing Clin Electrophysiol; 2016 Aug; 39(8):873-5. PubMed ID: 27198130
[No Abstract] [Full Text] [Related]
13. Implantable cardioverter-defibrillator discharges despite successful termination of ventricular tachycardia by antitachycardia pacing.
Ho RT
Pacing Clin Electrophysiol; 2009 Jun; 32(6):791-3. PubMed ID: 19545344
[No Abstract] [Full Text] [Related]
14. Failure of an implantable cardioverter-defibrillator to detect sustained ventricular tachycardia: a consequence of the latching phenomenon.
Altman EJ; Gross JN; Fisher JD; Krumerman A
Heart Rhythm; 2007 Jun; 4(6):785-7. PubMed ID: 17556204
[No Abstract] [Full Text] [Related]
15. Recurrence of ventricular tachycardia degeneration by low-energy implantable cardioverter-defibrillator shocks: a case report.
Cagli KE; Guray U; Akpinar I; Sen N; Aras D; Topaloglu S
J Electrocardiol; 2010; 43(1):68-70. PubMed ID: 19446839
[TBL] [Abstract][Full Text] [Related]
16. Flecainide in CASQ2-mediated catecholaminergic polymorphic ventricular tachycardia: the gift that keeps on giving.
Gopinathannair R
Heart Rhythm; 2013 Nov; 10(11):1676-7. PubMed ID: 23988695
[No Abstract] [Full Text] [Related]
17. Advances in the diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia.
Roston TM; Cunningham TC; Sanatani S
Cardiol Young; 2017 Jan; 27(S1):S49-S56. PubMed ID: 28084961
[TBL] [Abstract][Full Text] [Related]
18. Death due to an implantable cardioverter defibrillator.
Messali A; Thomas O; Chauvin M; Coumel P; Leenhardt A
J Cardiovasc Electrophysiol; 2004 Aug; 15(8):953-6. PubMed ID: 15333095
[TBL] [Abstract][Full Text] [Related]
19. Apparent inappropriate shocks from an implantable cardioverter defibrillator:
Moore DR; Kok LC; Vijayaraman P
J Cardiovasc Electrophysiol; 2004 Jan; 15(1):116-7. PubMed ID: 15028086
[No Abstract] [Full Text] [Related]
20. Hazards of antitachycardia pacing to treat ventricular tachycardias with implantable cardioverter defibrillators.
Maass AH; Van Gelder IC
Europace; 2009 Jun; 11(6):819. PubMed ID: 19357140
[No Abstract] [Full Text] [Related]
[Next] [New Search]
